Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Oct 28 - Nov 2
This dual-compound approach targets both GLP-1 and GIP receptors simultaneously, potentially accelerating weight loss in patients with genetic predispositions favoring dual-pathway activation
It has never received FDA approval for human use, and standard drug screens generally do not include assays for peptides like BPC-157
Unlike regular IGF-1, which acts for just a few minutes, IGF-1 LR3 remains active for hours, ensuring a more sustained impact on your body
Plan around your injection day At 50 units (especially at higher mg doses), the day of injection and the following day may bring stronger side effects
US$ 29.81
US$ 20.33
US$ 25.41
US$ 22.32
US$ 23.36
US$ 28.34
US$ 29.17
